2021/12/4  
英文 English 
New Zealand approves Taiwan-made Medigen vaccine for entry from Nov. 1 (2021/10/05)

The domestically made Medigen vaccine has gotten a vote of confidence from New Zealand. The country says that starting from Nov. 1, all foreign arrivals will need to show proof of full vaccination. Twenty-two COVID vaccines will be accepted as proof, and one of them is Medigen. In related news, Taiwan has now passed six days in a row with no new local cases. More than 57% of the population has received at least one dose of a COVID vaccine.

Tuesday marked six days in a row with zero local COVID infections.

On Monday, 208,000 vaccines were administered, bringing single-dose coverage to 57.67%. Taiwan is on track to reach 60% before National Day on Sunday.

Chen Shih-chung
Health minister
Yesterday there were fewer first doses administered, just over 27,000 doses. Most vaccines administered were second doses – there were 180,000 second doses.

So far, 503,000 people have been fully vaccinated with the Taiwan-developed Medigen vaccine. Amid concerns that Medigen would not be recognized overseas, New Zealand has given the brand a boost of confidence. Starting in November, all international visitors above the age of 17 must be fully vaccinated.

Twenty-two vaccines are approved for entry, and one of them is Medigen.

In addition, the CECC said that more Moderna vaccines were on the way. The new delivery will first go to people who need a second dose, it said.

Chen Shih-chung
Health minister
Moderna vaccines should be arriving soon. We will be able to provide more details in the next couple days.

The CECC plans to carry antibody tests on 5,000 serum samples taken from blood donations.

Chen Shih-chung
Health minister
We aim to get an understanding of past COVID spread and infection patterns. We’ll contrast that with our contact-tracing work and data on symptom onset. It can serve as a basis for monitoring the disease.

The CECC is working with the Taiwan Blood Services Foundation on the testing project. Anonymous samples will be taken from blood donations for serum testing. Once the samples are analyzed, all data will be destroyed. There will be no way to trace back whose blood was analyzed, it said.

The project will be initiated, pending an ethical review. Samples will be collected from donations made between April 25 and July 3.
中文 Chinese  
紐西蘭11月起開放打2劑旅客入境 認可疫苗含高端

好消息頻傳,連續第6天本土病例「加零」,最新全台涵蓋率也衝到57.67%,而完成高端兩劑施打的50.3萬的人,紐西蘭宣布11月起,開放完整接種旅客入境,22種疫苗就包括高端疫苗!國內還將展開抽驗5千位捐血者的「血清抗體監測計畫」,希望了解社區中自然感染或接種疫苗的抗體陽性比例與趨勢變化。

連續六天"嘉玲"報到,沒有本土案例。

前一天單日接種20.8萬劑,讓涵蓋率衝上57.67%,可望提前在國慶六成達標。

[[疫情指揮中心指揮官 陳時中]]
“昨天當然第一劑,打的比較少,是2萬7千多,第二劑打得比較多,是18萬”

目前有50.3萬人,已經打完兩劑高端,原本不少人擔心國際不承認,但像紐西蘭政府宣布11月起,開放完整接種疫苗的17歲以上外籍旅客入境。

允許22家國際疫苗廠牌中,就包括台製疫苗高端,好消息接二連三,近日又將有莫德納到貨,優先提供第二劑。

[[疫情指揮中心指揮官 陳時中]]
“莫德納疫苗應該我想,近日就會到來了,大概這兩天就可以,跟大家來做報告”

儘管疫情減緩,指揮中心再宣布,將蒐集5000 名捐血者的血清,進行抗體監測計畫。

[[疫情指揮中心指揮官 陳時中]]
“了解在各個地區以前,傳染的一個情況,還有染疫的情形,跟我們相關的疫調,跟我們最後發病確診的情況,可以做一個比較,做一個監測的基礎”

指揮中心和血液基金會合作,抽樣捐血者血液,進行匿名血清存檔,蒐集起來進一步檢驗分析,最後會通通銷毀,所有資料都無法辨識回溯。計畫正在進行倫理審查,抽驗抗體區間,鎖定4/25-7/3的捐血人。
關於民視 常見問題 如何收看民視 意見信箱

© 2009 FTV All Rights Reserved 版權所有‧盜用必究 Designed by FTV
地址:244 新北市林口區信義路99號   觀服電話:(02)8601-8601 服務時間:週一至週日09:00-21:00   傳真:(02)8601-3955

本網站使用 cookie 與其他技術為您提供更好的使用體驗, 請閱讀我們的的隱私權政策,通過使用我們的網站,表示您確認並同意我們的政策。